Dashboard
Manage Tickers

AKBA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

akebia-therapeutics-and-innovative-renal-care-announce--vafseo-availability-in-irc-dialysis-clinics
Akebia Therapeutics And Innovative Renal C...
08/21/2025 12:10:09

akebia-therapeutics-q2-sales-62472m-beat-47637m-estimate
Akebia Therapeutics Q2 Sales $62.472M Beat...
08/07/2025 11:03:41

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly sales of $62.472 million which beat the analyst consensus estimate of $47....

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

earnings-preview-for-akebia-therapeutics
Earnings Preview For Akebia Therapeutics
08/06/2025 19:03:28

akebia-therapeutics-initiates-post-marketing-study-to-identify-additional-potential-benefits-of-vafseo
Akebia Therapeutics Initiates Post-Marketi...
08/04/2025 12:09:08

Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted b...

Core News & Articles
9 Health Care Stocks Whale Activity In Tod...
06/04/2025 17:35:27

akebia-therapeutics-announces-publication-in-jasn-of-us-and-non-us-subgroup-analyses-from-vadadustat-global-phase-3-trials-showing-comparable-safety-and-efficacy-in-dialysis-dependent-ckd-patients-and-highlighting-elevated-mace-risk-in-us-nondialysis-dependent-ckd-patients
Akebia Therapeutics Announces Publication ...
06/04/2025 12:19:56

Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted b...

hc-wainwright--co-assumes-akebia-therapeutics-at-buy-announces-price-target-of-8
HC Wainwright & Co. Assumes Akebia Therape...
06/04/2025 11:20:49

HC Wainwright & Co. analyst Matthew Caufield assumes Akebia Therapeutics (NASDAQ:AKBA) with a Buy rating and announces P...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/08/2025 12:07:05

akebia-therapeutics-q1-eps-003-beats-004-estimate-sales-5734m-beat-4488m-estimate
Akebia Therapeutics Q1 EPS $0.03 Beats $(0...
05/08/2025 11:06:00

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $...

Core News & Articles
Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

insights-ahead-akebia-therapeuticss-quarterly-earnings
Insights Ahead: Akebia Therapeutics's Quar...
05/07/2025 15:03:16

hc-wainwright--co-reiterates-buy-on-akebia-therapeutics-maintains-75-price-target
HC Wainwright & Co. Reiterates Buy on Akeb...
04/04/2025 10:58:11

HC Wainwright & Co. analyst Ed Arce reiterates Akebia Therapeutics (NASDAQ:AKBA) with a Buy and maintains $7.5 price tar...

akebia-therapeutics-announces-committee-for-medicinal-products-for-human-use-of-the-european-medicines-agency-has-adopted-a-positive-opinion-recommending-the-european-commission-to-approve-xoanacyl-for-treatment-of-concomitant-elevated-serum-phosphorous-and-iron-deficiency-in-adult-patients-with-chronic-kidney-disease
Akebia Therapeutics Announces Committee Fo...
04/03/2025 12:15:19

Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted b...

jefferies-initiates-coverage-on-akebia-therapeutics-with-buy-rating-announces-price-target-of-6
Jefferies Initiates Coverage On Akebia The...
04/01/2025 12:07:25

Jefferies analyst Roger Song initiates coverage on Akebia Therapeutics (NASDAQ:AKBA) with a Buy rating and announces Price T...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/20/2025 17:06:07

crude-oil-gains-over-1-us-weekly-jobless-claims-increase
Crude Oil Gains Over 1%; US Weekly Jobless...
03/20/2025 16:01:03

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/20/2025 12:09:53

reported-earlier-akebia-therapeutics-prices-50m-public-offering-of-25m-common-shares-at-2share
Reported Earlier, Akebia Therapeutics Pric...
03/20/2025 05:59:53

The gross proceeds to Akebia from the Offering, before deducting underwriting discounts, commissions and other offering expense...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/19/2025 21:06:24

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION